Petershill Partners (LON: PHLL) has announced an 11% increase in Distributable Partnership Income to $323 million by 2024, along with strong asset growth and acquisitions, sending its shares up more than 2% on the day of the announcement.
The UK investment firm completed four acquisitions totalling $205 million and three disposals, generating a notional value of $575 million.
During the year, Petershill returned $563 million to shareholders, including an interim dividend of $54 million, a proposed final dividend of $114 million, special dividends totalling $287 million, a tender offer of $103 million and a buyback of $6 million.
After the end of the financial year, the company completed another acquisition and disposal and announced a special dividend of $151 million.
Adjusted profit after tax was $216 million, up from $200 million in 2023. Adjusted EBIT increased to $293 million, maintaining a high profit margin of 88%, while IFRS profit after tax increased to $832 million from $321 million in the previous year. IFRS earnings per share increased to 75.8 cents from 28.4 cents in 2023.
The acquisitions included a stake in Kennedy Lewis Investment Management and additional interests in three existing partnerships.
The sale of the partnership interests generated $575 million in nominal value, 19% higher than the book value at the time of the transaction.
The Board of Directors recommended a final dividend of 10.5 cents per share, bringing the total dividend for the year to 15.5 cents per share, up from 15.0 cents in 2023.
A special dividend of 14.0 cents per share, or $151 million, was also declared, primarily repaying the proceeds from the sale of the General Catalyst stake, which was completed in early 2025.
The sale of a majority of the General Catalyst stake was completed for a total nominal value of $726 million, 62% higher than the last reported book value before the disposal.
In 2024, Partner Fee-Related Income increased by 11% to $225 million, with net management fees increasing by 10% year-on-year. Partner performance revenue increased 33% to $73 million, accounting for 15% of total partner revenue.
Private markets partner accrued interest increased 14% to $702 million.
Petershill’s partner firms saw asset growth, with total assets under management reaching $337 billion, up 11%, and fee-based assets under management increasing to $238 billion, up 8%.
The firm also raised $32 billion in total fee-eligible assets during the year, exceeding its target range.
Fair value investments increased 11% to $5.8 billion. The firm ended the year with $23 million in cash and money market fund investments, down from $305 million in 2023 due to capital gains during the period.
Free cash flow conversion was reported at 82%, and book value per share increased to 471 cents from 431 cents.
For 2025, Petershill targets to raise $20 billion to $25 billion in fee-eligible assets and realize $5 billion to $10 billion in fee-paying assets.
Partner fee-related income is expected to be $180 million to $210 million, with Partner Performance Revenue expected to account for 15% to 30% of total partner revenue.
The company expects acquisitions to be above its mid-term target range of $100 million to $300 million per year and adjusted EBIT margins of 85% to 90%.
Later in the year, Petershill Partners acquired a stake in Frazier Healthcare Partners for $330 million, with an initial $16 million funded at closing and the remaining $314 million deferred primarily in 2026 and 2027.
Frazier Healthcare Partners is a healthcare-focused private equity firm with $5.5 billion in assets.
With its valuation soaring into 2024, many investors are wondering if PHLL is a good investment right now. ProPicks AI provides 6 portfolio models from Investing.com that help identify the best stocks for investors to buy right now. The new monthly stock picks could deliver significant returns in the years ahead. Is PHLL one of them?